Transphorm, Inc. Common Stock
TGAN
TGAN was delisted on the 20th of June, 2024.
41 hedge funds and large institutions have $151M invested in Transphorm, Inc. Common Stock in 2023 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 21 increasing their positions, 6 reducing their positions, and 1 closing their positions.
300% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 1
250% more repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 6
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
66% more capital invested
Capital invested by funds: $90.5M → $151M (+$60M)
5% more funds holding
Funds holding: 39 → 41 (+2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Ameriprise
Minneapolis,
Minnesota
|
+$1.37M |
| 2 |
BlackRock
New York
|
+$628K |
| 3 |
Morgan Stanley
New York
|
+$286K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$164K |
| 5 |
Barclays
London,
United Kingdom
|
+$95.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SFM
Soros Fund Management
New York
|
-$755K |
| 2 |
Nisa Investment Advisors
St. Louis,
Missouri
|
-$10.8K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
-$6.58K |
| 4 |
Invesco
Atlanta,
Georgia
|
-$4.92K |
| 5 |
California State Teachers Retirement System (CalSTRS)
West Sacramento,
California
|
-$3.77K |
TGAN Hedge Fund Activity: Q4 2023 in Review
41 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Transphorm, Inc. Common Stock (TGAN) for Q4 2023, worth a combined $151M — up 66% from $90.5M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new TGAN positions and 1 closed out — a net gain of 3 holders — while 21 added to existing stakes and 6 trimmed.
The largest buyer was Ameriprise, adding an estimated $1.37M. The largest seller was Soros Fund Management, exiting entirely with an estimated $755K sold.
- 41 institutional investors held Transphorm, Inc. Common Stock (TGAN) as of Q4 2023, up from 39 in Q3 2023.
- Funds reported $151M of Transphorm, Inc. Common Stock stock for Q4 2023, up 66% quarter-over-quarter.
- 4 funds opened new Transphorm, Inc. Common Stock positions in Q4 2023 and 1 closed out, a net change of +3 holders.
- The largest Transphorm, Inc. Common Stock buyer in Q4 2023 was Ameriprise, an estimated $1.37M added.
- The largest Transphorm, Inc. Common Stock seller in Q4 2023 was Soros Fund Management, an estimated $755K sold.
Based on aggregated 13F filings for Q4 2023.